Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -98.53%.However, over the last six months, we can see a stronger performance of -96.36%. Over the last 30 days, the price of TNXP has fallen by 22.86%. And in the last five days, it has fallen by -7.10%.
Tonix Pharmaceuticals Holding Corp ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $22.14 on 12/19/23, while the lowest value for the same period was recorded at $0.12 on 10/03/24.
52-week price history of TNXP Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Tonix Pharmaceuticals Holding Corp’s current trading price is -99.14% away from its 52-week high, while its distance from the 52-week low is 60.76%. The stock’s price range during this time has been between $0.12 and $22.14. The trading volume for the Healthcare sector company’s shares reached about 29.0 million for the day, which was lower than the average daily volume of 36.79 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -17.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 35.71M and boasts a workforce of 103 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2741, with a change in price of -0.4303. Similarly, Tonix Pharmaceuticals Holding Corp recorded 31,722,922 in trading volume during the last 100 days, posting a change of -69.40%.
TNXP’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNXP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.
TNXP Stock Stochastic Average
Today, Tonix Pharmaceuticals Holding Corp’s raw stochastic average for the past 50 days stands at 45.29%, indicating a rise from the raw stochastic average of the last 20 days, which was 42.23%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 41.61% and 41.75% respectively.
